| Patents for C07D 311 - Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings (24,127) |
|---|
| 09/13/2006 | CN1274670C Diaminopropionic acid derivatives |
| 09/12/2006 | US7105686 Reaction of methylhydroquinone in the presence of Gadolinium trifluoromethanesulfonate with phytol or isophytol to form tocol or tocopherol |
| 09/12/2006 | US7105685 Viricides treating Human Immunodeficiency Viruses; antitumor agents |
| 09/12/2006 | US7105542 Chromone compound; also viricide, antiinflammatory agents |
| 09/12/2006 | US7105471 Arylphenyl-substituted cyclic ketoenols |
| 09/12/2006 | US7105268 One monomer unit represented by following Formula (I): wherein R1, R2, R3, R4 and R5 are the same or different and are each a hydrogen atom or a methyl group; m, p and q each denote an integer of from 0 to 2; and n denotes 0 or 1, where the |
| 09/12/2006 | CA2214096C Process for the preparation of aromatic carbamoyl-substituted polysaccharide derivatives |
| 09/08/2006 | WO2006093339A1 Use of cinnamoyl compound |
| 09/08/2006 | WO2006093336A1 Use of cinnamoyl compound |
| 09/08/2006 | WO2006093083A1 Crosslinking agent, crosslinking method, method of controlling gene expression and method of examining gene function |
| 09/08/2006 | WO2006092086A1 A method for the preparation of dl-nebivovol and its hydrochloride salt |
| 09/08/2006 | WO2006092081A1 Insulin analogs from euphorbia lunulata extracts and the use thereof and the use of interleukin-10 analogs |
| 09/08/2006 | CA2600287A1 Use of cinnamoyl compound |
| 09/07/2006 | US20060199957 Novel bicyclic and tricyclic cannabinoids |
| 09/07/2006 | US20060199859 Topical medicaments and methods for photodynamic treatment of disease |
| 09/07/2006 | US20060199858 Substituted benzopyrans as selective estrogen receptor-beta agonists |
| 09/06/2006 | EP1698629A2 Polyamines and their use in therapy |
| 09/06/2006 | EP1697341A2 Production of dihydronepetalactone by reduction of nepetalic acid |
| 09/06/2006 | EP1697340A1 Process for purifying (-)-d9-trans-tetrahydrocannabinol |
| 09/06/2006 | EP1697292A1 Method for the production of tetrahydrogeranylacetone |
| 09/06/2006 | EP1696902A2 Compositions containing d-tocopherol compound polybasic acid partial esters |
| 09/06/2006 | EP1409490B1 2-(aminomethyl)-tetrahydro-9-oxa-1,3-diaza-cyclopenta a|naphthalenyl derivatives with antipsychotic activity |
| 09/06/2006 | EP1253909B1 Pharmaceutical formulations comprising labdanes for the treatment of tumors or leukemias |
| 09/06/2006 | EP0984053B1 Photochromic polymerizable composition |
| 09/06/2006 | CN1829786A Chroman derivative and liquid-crystal composition containing the compound |
| 09/06/2006 | CN1829506A Novel coumarin-amide derivatives and its preparation, its drug composition and use |
| 09/06/2006 | CN1827614A Process for extracting flavonoid compounds from fiber board hot-grinding waste water |
| 09/06/2006 | CN1827613A Separation of licoflavone from liquorice by solvent extraction method |
| 09/06/2006 | CN1827612A Process for synthesizing daphnetin |
| 09/06/2006 | CN1273471C Method for producing glabridin product |
| 09/06/2006 | CN1273123C Application of (3R,4R)-delta 8-tetrahydrocannabinol)-11-acid in preparation of medicine for reducing cell proliferation |
| 09/05/2006 | US7102020 Total synthesis of daurichromenic acid |
| 09/05/2006 | US7102005 Diagnosing the presence or absence of polyneuropathy by assessing the presence or absence of antibodies which bind to a heparin oligosaccaride; quantitative analysis by enzyme-linked immunoabsorbent assay; kits |
| 09/05/2006 | US7101917 Mitochrondrial permeability transition pore affinity labels and modulators |
| 09/05/2006 | US7101533 Agent for inducing receptor potential |
| 08/31/2006 | WO2006091246A1 Novel compounds for treatment of cancer and disorders associated with angiogenesis function |
| 08/31/2006 | WO2006090830A1 Method of producing proanthocyanidin oligomer |
| 08/31/2006 | WO2006026368A3 Development of fluorogenic substrates for monoamine oxidases (mao-a and mao-b) |
| 08/31/2006 | US20060194872 Diamine derivative, production process therefor and antioxidant |
| 08/31/2006 | US20060194871 Heterocyclic mchr1 antagoists |
| 08/31/2006 | US20060194866 Less toxicity; side effects redution; substituted p-chlorobenzene and a pyrrolethoxybenzene |
| 08/31/2006 | US20060194817 N-{(1S,2R)-1-(3,5-difluorobonzyl)-2-hydroxy-3-[(3-iodobonzyl)amino]propyl}-2-{4-[(methylsulfonyl)amino]phenyl}acetamide; inhibitors of the beta- secretase enzyme useful in the treatment of Alzheimer's disease and other diseases characterized by deposition of A beta peptide in a mamma |
| 08/31/2006 | US20060194761 Olivetol-cyclodextrin complexes and regio-selective process for preparing delta 9-tetrahydrocannabinol |
| 08/31/2006 | US20060194256 Compositions containing, methods involving, and uses of non-natural amino acids and polypeptides |
| 08/31/2006 | US20060193797 Chroman derivatives as lipoxygenase inhibitors |
| 08/31/2006 | CA2599295A1 Method of producing proanthocyanidin oligomer |
| 08/31/2006 | CA2586080A1 Novel compounds for treatment of cancer and disorders associated with angiogenesis function |
| 08/30/2006 | EP1694664A1 2- ( (2, 3-dihydroxypropyl) aminomethyl) chromane derivatives for use as beta-3 adrenoreceptor agonists in the treatment of urological and inflammatory disorders |
| 08/30/2006 | EP1694627A2 Novel ligands that are activators of the rar receptors, use in human medicine and in cosmetics |
| 08/30/2006 | EP1412343B1 Compounds, which are potent inhibitors of na+/ca2+ exchange mechanism and are useful in the treatment of arrhythmias |
| 08/30/2006 | CN1826331A Pi-3 kinase inhibitor prodrugs |
| 08/30/2006 | CN1824661A Method of preparing soyabean isoflarone from low temperature soya dreg |
| 08/30/2006 | CN1824660A Benzopyran kind compound and its preparation method |
| 08/30/2006 | CN1272332C Red clover total flavone high content extract, preparation and application in pharmaceutical combination thereof |
| 08/30/2006 | CN1272331C Method of extracting three effective components in kudzu vine root |
| 08/30/2006 | CN1272324C Novel herbicides |
| 08/30/2006 | CN1271999C Use of extracts and preparations from iris plants and tectorigenin as organ selective medicament for treating urethra disease |
| 08/29/2006 | US7098347 Process for the preparation of 1-hydroperoxy-16-oxabicyclo[10.4.0]hexadecane |
| 08/29/2006 | US7098340 Quinoline/chromene derivatives as androgen antagonist |
| 08/29/2006 | US7098215 Nitrogenous compounds and antiviral drugs containing the same |
| 08/29/2006 | US7098202 Amino acid hydroxyethylamino sulfonamide retroviral protease inhibitors |
| 08/29/2006 | US7098199 Administering a polycyclic sulfamate ester that is replaced with a sulfate group and incubated with a seroid sulphatase enzyme at 7.4 pH and 37 degrees C to provide a Km value of < 50 micrometers |
| 08/29/2006 | CA2258152C Novel aromatic derivatives substituted by a ribose, their method of preparation and application as medicine |
| 08/29/2006 | CA2212856C Benzopyran-containing compounds and method for their use |
| 08/24/2006 | WO2006088716A1 Substituted tetralins as selective estrogen receptor-beta agonists |
| 08/24/2006 | WO2006065686A3 Spiro derivatives as lipoxygenase inhibitors |
| 08/24/2006 | WO2006056850A3 Chroman compounds |
| 08/24/2006 | US20060189815 Liquid-liquid extraction, urea inclusion compound formation and fractionation, followed by vacuum distillation to further separating free fatty acids and monoacylglycerols to obtain tocotrienol concentrate; recovery of minor components from oils and fats without destroying the natural components |
| 08/24/2006 | US20060189674 Deacetylase inhibitors |
| 08/24/2006 | US20060189611 Amino acid hydroxyethylamino sulfonamide retroviral protease inhibitors |
| 08/24/2006 | US20060189542 Preventive or therapeutic composition for viral infectious disease |
| 08/24/2006 | US20060188915 Atropisomers of asymmetric xanthene fluorescent dyes and methods of dna sequencing and fragment analysis |
| 08/24/2006 | DE10218512B4 Lichtempfindliches Polymer und Resist-Zusammensetzungen The light-sensitive polymer and resist compositions |
| 08/23/2006 | EP1693060A1 Therapeutic or preventive agents for ischemic neuropathy |
| 08/23/2006 | EP1692125A2 Irciniastatins a and b |
| 08/23/2006 | EP1691800A1 Methods and agents for inhibiting dynamin-dependent endocytosis |
| 08/23/2006 | EP1504000A4 4-thio coumarins |
| 08/23/2006 | EP1369489B1 Flavonoid compound and process for producing the same |
| 08/23/2006 | EP1180516B1 Methods for purifying proanthocyanidin oligomers |
| 08/23/2006 | EP0837052B1 Bicyclic amino derivatives and pgd 2 antagonist containing the same |
| 08/23/2006 | CN1823052A Benzopyrone compounds and its preparation and use |
| 08/23/2006 | CN1822829A 7-carboxymethyloxy-3', 4', 5-trimethoxy flavone monohydrate, the preparation method and uses thereof |
| 08/23/2006 | CN1821255A Total giamt St.John' swort Herb flavone extract, its preparing method and use |
| 08/23/2006 | CN1821239A Process for preparing oxa anthracene compound |
| 08/23/2006 | CN1821238A Improving the quality of crude oils and fats and recovery of minor components |
| 08/23/2006 | CN1821237A Method for extracting flavone compound asparagus and its leftover |
| 08/23/2006 | CN1821236A Therapeutic heterocyclic compounds |
| 08/23/2006 | CN1821217A Process for producing trans-4-amino-1-cyclohexanecarboxylic acid derivative |
| 08/23/2006 | CN1271065C Manufacture of alpha- tocopherol |
| 08/23/2006 | CN1271064C Extraction method of high-content EGCg catechin |
| 08/22/2006 | US7094914 Reducing a nitrochromone compound containing an acid or ester group with hydrogen in presence of a metal catalyst and a base in a solvent to produce aminochromone intermediate |
| 08/22/2006 | US7094807 Viricides; hepatitis virus |
| 08/22/2006 | US7094776 cyclohexane ring is 3,5-dihydroxy-substituted and 2,4-alkylene-bridged; treating metabolic bone disease including senile, postmenopausal, and steroid-induced osteoporosis, osteomalacia, renal osteodystrophy and rickets |
| 08/17/2006 | WO2006085978A2 Conjugates of a cephalosporin derivative and a fluorophor precursor and related compounds as substrates for beta-lactamase gene expression |
| 08/17/2006 | WO2006085510A1 Remedy for irritable bowel syndrome |
| 08/17/2006 | WO2005040489A3 Fluorescent through-bond energy transfer cassettes based on xanthine and pyronin derivatives |
| 08/17/2006 | US20060183924 Processes for the 3,3-dialkylation of 4-chromanones |
| 08/17/2006 | US20060183923 7-Hydroxy-3-(4-hydroxyphenyl)-2-[(phenylmethyl)thio]-4H-1-benzopyran-4-one, for example; reacting deoxybenzoins with a phase transfer catalyst to provide a 2-(alkylthio)isoflavone, deprotecting the 2-(alkylthio)isoflavon, and applying selective debenzylation to form the final compound |
| 08/17/2006 | US20060183922 CB2-selective cannabinoid derivatives |
| 08/17/2006 | US20060183870 Triamantane diamondoid nucleus |